Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas

Cancer, 05/02/2012

Rituximab, fludarabine, and cyclophosphamide (FCR) induction therapy followed by a short maintenance phase is a highly effective regimen with acceptable toxicity.

Print Article Summary